Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 35, 2022 - Issue 6
41
Views
0
CrossRef citations to date
0
Altmetric
Case Studies

Cefazolin-induced hypoprothrombinemia

, MDORCID Icon, , MD, , DO & , MD
Pages 868-870 | Received 15 Mar 2022, Accepted 27 Jun 2022, Published online: 13 Jul 2022

  • Kerremans AL, Lipsky JJ, Van Loon J, Gallego MO, Weinshilboum RM. Cephalosporin-induced hypoprothrombinemia: possible role for thiol methylation of 1-methyltetrazole-5-thiol and 2-methyl-1,3,4-thiadiazole-5-thiol. J Pharmacol Exp Ther. 1985;235(2):382–388.
  • Shimada K, Matsuda T, Inamatsu T, Urayama K. Bleeding secondary to vitamin K deficiency in patients receiving parenteral cephem antibiotics. J Antimicrob Chemother. 1984;14(Suppl B):325–330. doi:10.1093/jac/14.suppl_B.325.
  • Wood TC, Johnson KL, Naylor S, Weinshilboum RM. Cefazolin administration and 2-methyl-1,3,4-thiadiazole-5-thiol in human tissue: possible relationship to hypoprothrombinemia. Drug Metab Dispos. 2002;30(10):1123–1128. doi:10.1124/dmd.30.10.1123.
  • Chung AH, Watson K. Cefazolin-induced hypoprothrombinemia. Am J Health Syst Pharm. 2008;65(9):823–826. doi:10.2146/ajhp070243.
  • Barnes T, Yan S, Kaakeh Y. Necrotizing esophagitis and bleeding associated with cefazolin. Ann Pharmacother. 2014;48(9):1214–1218. doi:10.1177/1060028014537038.
  • Angles E, Mouton C, Perino J, Remy A, Ouattara A. Hypoprothrombinemia and severe perioperative haemorrhagic complications in cardiac surgery patients treated with high-dose cefazolin for infective endocarditis. Anaesth Crit Care Pain Med. 2018;37(2):167–170. doi:10.1016/j.accpm.2017.07.006.
  • Nichols RL, Wikler MA, McDevitt JT, Lentnek AL, Hosutt JA. Coagulopathy associated with extended-spectrum cephalosporins in patients with serious infections. Antimicrob Agents Chemother. 1987;31(2):281–285. doi:10.1128/AAC.31.2.281.
  • O’Donnell D. Hypoprothrombinaemia associated with use of cephamandole. Aust N Z J Surg. 1991;61(6):471–472.
  • Shearer MJ, Bechtold H, Andrassy K, et al. Mechanism of cephalosporin-induced hypoprothrombinemia: relation to cephalosporin side chain, vitamin K metabolism, and vitamin K status. J Clin Pharmacol. 1988;28(1):88–95. doi:10.1002/j.1552-4604.1988.tb03106.x.
  • Alitalo R, Ruutu M, Valtonen V, Lehtonen T, Pentikäinen PJ. Hypoprothrombinaemia and bleeding during administration of cefamandole and cefoperazone. Report of three cases. Ann Clin Res. 1985;17(3):116–119.
  • Almeida NEC, Stevens RW, Gurram P, Rivera CG, Suh GA. Cefazolin and rifampin: a coagulopathy-inducing combination. Am J Health Syst Pharm. 2021;78(24):2204–2208. doi:10.1093/ajhp/zxab210.
  • Rifadin (Rifampin) [Prescribing Information]. Bridgewater, NJ: Sanofi-Aventis; 2019.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.